Publications in collaboration with researchers from Instituto de Salud Carlos III (22)

2026

  1. Effectiveness and safety of daptomycin versus vancomycin in methicillin-resistant staphylococci left-sided infective endocarditis: results from a nationwide prospective, multicentre cohort

    Clinical Microbiology and Infection

2025

  1. A Contemporary Picture of Coagulase-Negative Staphylococcal Endocarditis: A Nationwide GAMES Cohort Study

    Journal of the American College of Cardiology, Vol. 85, Núm. 4, pp. 305-318

  2. High-risk Cytomegalovirus in Heart Transplant: How Can We Improve?

    Transplantation Proceedings, Vol. 57, Núm. 1, pp. 67-69

  3. Management of multidrug-resistant gram-negative bacilli infections in adult solid organ transplant recipients: GESITRA-IC/SEIMC, CIBERINFEC, and SET recommendations update.

    Transplantation Reviews, Vol. 39, Núm. 3

2024

  1. Evolution of the impact of the COVID-19 pandemic on heart transplant recipients: Decreasing risk, improving perspective

    Transplant Infectious Disease, Vol. 26, Núm. 2

  2. Infective endocarditis in pediatric patients: a decade of insights from a leading Spanish heart surgery reference center

    European Journal of Pediatrics, Vol. 183, Núm. 9, pp. 3905-3913

2022

  1. Derivation of a score to predict infection due to multidrug-resistant Pseudomonas aeruginosa: a tool for guiding empirical antibiotic treatment

    Journal of Global Antimicrobial Resistance, Vol. 29, pp. 215-221

  2. Fidaxomicin monotherapy versus standard therapy combined with bezlotoxumab for treating patients with Clostridioides difficile infection at high risk of recurrence: a matched cohort study

    The Journal of antimicrobial chemotherapy, Vol. 77, Núm. 7, pp. 1996-2002

  3. Non-Tuberculous Mycobacteria and Aspergillus Lung Co-Infection: Systematic Review

    Journal of Clinical Medicine, Vol. 11, Núm. 19

  4. Role of cytomegalovirus infection after kidney transplantation on the subsequent risk of atherosclerotic and thrombotic events

    Atherosclerosis Plus, Vol. 48, pp. 37-46

  5. The impact of COVID-19 pandemic on pulmonary hypertension: What have we learned?

    Pulmonary Circulation, Vol. 12, Núm. 4

2021

  1. Efficacy of β-lactam/β-lactamase inhibitors to treat extended-spectrum beta-lactamase-producing Enterobacterales bacteremia secondary to urinary tract infection in kidney transplant recipients (INCREMENT-SOT Project)

    Transplant infectious disease : an official journal of the Transplantation Society, Vol. 23, Núm. 3, pp. e13520

  2. Impact of the COVID-19 pandemic on the diagnosis, management and prognosis of infective endocarditis

    Clinical Microbiology and Infection

  3. Invasive aspergillosis in solid organ transplantation: Diagnostic challenges and differences in outcome in a Spanish national cohort (Diaspersot study)

    Mycoses, Vol. 64, Núm. 11, pp. 1334-1345

  4. Real-world experience with bezlotoxumab for prevention of recurrence of clostridioides difficile infection

    Journal of Clinical Medicine, Vol. 10, Núm. 1, pp. 1-9

2020

  1. Pre-existing Hemagglutinin Stalk Antibodies Correlate with Protection of Lower Respiratory Symptoms in Flu-Infected Transplant Patients

    Cell Reports Medicine, Vol. 1, Núm. 8

  2. Predictive tools to determine risk of infection in kidney transplant recipients

    Expert Review of Anti-Infective Therapy, Vol. 18, Núm. 5, pp. 423-441

2019

  1. Monitoring of alphatorquevirus DNA levels for the prediction of immunosuppression-related complications after kidney transplantation

    American Journal of Transplantation, Vol. 19, Núm. 4, pp. 1139-1149

2018

  1. Vitamin D deficiency and infection risk in kidney transplant recipients: A single-center cohort study

    Transplant Infectious Disease, Vol. 20, Núm. 6

2017

  1. Environmental factors as key determinants for visceral leishmaniasis in solid organ transplant recipients, Madrid, Spain

    Emerging Infectious Diseases, Vol. 23, Núm. 7, pp. 1155-1159